A higher BPC 157 dosage may speed up muscle development or recovery, but it could also increase the risk of side effects
Two defaults that both land on 10 units (0.1 mL) per dose on a U-100 insulin syringe: Skincare 2 mg GHK-Cu anchor, reconstitute the 80 mg vial with 2.5 mL BAC water
Primary endpoint: composite MACE (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke)
Originally derived from a protein found in the stomach lining, BPC157 shows promising effects on everything from tendon repair to intestinal regeneration and its use is rapidly expanding in the performance, biohacking, and longevity communities
Whether its slow recovery, chronic inflammation, or unexplained fatigue, the goal is to trace it back to a measurable disruption something we can map, track, and correct with precision
The combination approach (CagriSema) offers theoretical advantages in flexibility